A Godál

653 total citations
28 papers, 526 citations indexed

About

A Godál is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, A Godál has authored 28 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Biotechnology and 6 papers in Molecular Biology. Recurrent topics in A Godál's work include Toxin Mechanisms and Immunotoxins (13 papers), Transgenic Plants and Applications (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). A Godál is often cited by papers focused on Toxin Mechanisms and Immunotoxins (13 papers), Transgenic Plants and Applications (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). A Godál collaborates with scholars based in Norway, United States and Slovakia. A Godál's co-authors include Øystein Fodstad, Alexander Pihl, Siri Juell, Sjur Olsnes, Walter A. Hall, Gunnar Kvalheim, Johan Moan, Anne Pharo, J. M. Nesland and Qian Peng and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of neurosurgery and British Journal of Cancer.

In The Last Decade

A Godál

27 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Godál Norway 15 307 187 178 109 86 28 526
Virginia Gray Johnson United States 7 331 1.1× 145 0.8× 321 1.8× 59 0.5× 133 1.5× 8 711
M. G. Rosenblum United States 13 251 0.8× 98 0.5× 171 1.0× 50 0.5× 134 1.6× 26 575
Larry D. Greenfield United States 8 216 0.7× 127 0.7× 124 0.7× 43 0.4× 83 1.0× 14 400
Jinbiao Zhan China 13 109 0.4× 60 0.3× 258 1.4× 69 0.6× 170 2.0× 29 541
Thierry Marysael Belgium 4 360 1.2× 50 0.3× 207 1.2× 152 1.4× 220 2.6× 5 719
Г. И. Дейчман Russia 14 160 0.5× 63 0.3× 214 1.2× 33 0.3× 216 2.5× 41 554
Arati Limaye United States 6 143 0.5× 75 0.4× 178 1.0× 75 0.7× 128 1.5× 10 511
Sergey A. Kaliberov United States 15 273 0.9× 97 0.5× 368 2.1× 91 0.8× 304 3.5× 25 825
E Satoh Japan 9 96 0.3× 66 0.4× 241 1.4× 87 0.8× 112 1.3× 12 487
Ann‐Charlotte Björklund Sweden 7 438 1.4× 38 0.2× 268 1.5× 61 0.6× 252 2.9× 12 791

Countries citing papers authored by A Godál

Since Specialization
Citations

This map shows the geographic impact of A Godál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Godál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Godál more than expected).

Fields of papers citing papers by A Godál

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Godál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Godál. The network helps show where A Godál may publish in the future.

Co-authorship network of co-authors of A Godál

This figure shows the co-authorship network connecting the top 25 collaborators of A Godál. A scholar is included among the top collaborators of A Godál based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Godál. A Godál is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godál, A, et al.. (2006). New Derivatives of 5-Aminolevulinic Acid for Photodynamic Therapy: Chemical Synthesis and Porphyrin Production in In Vitro and In Vivo Biological Systems. Journal of Environmental Pathology Toxicology and Oncology. 25(1-2). 109–126. 14 indexed citations
2.
Peng, Qian, Trond Warloe, Johan Moan, et al.. (2001). Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.. PubMed. 61(15). 5824–32. 64 indexed citations
3.
Wen, Dennis Y., Walter A. Hall, John A. Conrad, et al.. (1995). In Vitro and In Vivo Variation in Transferrin Receptor Expression on a Human Medulloblastoma Cell Line. Neurosurgery. 36(6). 1158–1164. 14 indexed citations
4.
Hall, Walter A., et al.. (1994). In Vivo Efficacy of Intrathecal Transferrin-Pseudomonas Exotoxin A Immunotoxin against LOX Melanoma. Neurosurgery. 34(4). 649–656. 22 indexed citations
5.
Fuchsberger, N, et al.. (1993). In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test.. PubMed. 40(5). 293–6. 4 indexed citations
6.
Godál, A, et al.. (1992). Immunotoxins directed against the high‐molecular‐weight melanoma‐associated antigen. Identification of potent antibody‐toxin combinations. International Journal of Cancer. 52(4). 631–635. 24 indexed citations
7.
Hall, Walter A., A Godál, Siri Juell, & Øystein Fodstad. (1992). In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. Journal of neurosurgery. 76(5). 838–844. 45 indexed citations
8.
Godál, A, Øystein Fodstad, & Alexander Pihl. (1988). Kinetics of uptake and degradation of an abrin immijnotoxin by melanoma cells and studies of the rates of cellular intoxication. International Journal of Cancer. 42(3). 400–404. 4 indexed citations
9.
Fodstad, Øystein, Gunnar Kvalheim, Alexander Pihl, A Godál, & S. Funderud. (1988). New Indirect Approach to the Therapeutic Use of Immunotoxins. JNCI Journal of the National Cancer Institute. 80(6). 439–443. 15 indexed citations
10.
Godál, A, Øystein Fodstad, & Alexander Pihl. (1987). Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines.. PubMed. 47(23). 6243–7. 19 indexed citations
11.
Godál, A, Øyvind S. Bruland, Erik Skaaheim Haug, Magne Aas, & Øystein Fodstad. (1986). Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells. British Journal of Cancer. 53(6). 839–841. 23 indexed citations
12.
Godál, A, et al.. (1984). Pharmacological studies of ricin in mice and humans. Cancer Chemotherapy and Pharmacology. 13(3). 157–163. 15 indexed citations
13.
Fodstad, Øystein, Gunnar Kvalheim, A Godál, et al.. (1984). Phase I study of the plant protein ricin.. PubMed. 44(2). 862–5. 58 indexed citations
14.
Godál, A, Øystein Fodstad, & Alexander Pihl. (1983). Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice. International Journal of Cancer. 32(4). 515–521. 33 indexed citations
15.
Benešová, Monika, et al.. (1979). Carcinogenicity and polarographic behaviour of dibenzo[a,h]pyrene, 4,11-diazadibenzo[a,h]pyrene and 7,14-diazadibenzo[a,h]pyrene.. PubMed. 26(1). 23–8. 1 indexed citations
16.
Benešová, Monika, et al.. (1978). Carcinogenicity and polarographic behavior of dibenz[a,h]anthracene, dibenz[a,h]acridine and dibenz[a,h]phenazine.. PubMed. 25(6). 641–5. 3 indexed citations
17.
Godál, A, et al.. (1975). Long-term results in rectum carcinoma. Patients followed up during the period 1959-1968.. PubMed. 22(6). 661–72. 1 indexed citations
18.
Godál, A, et al.. (1973). Long-term results of breast cancer treatment during 1959-1966.. PubMed. 20(4). 443–55. 1 indexed citations
19.
Godál, A, et al.. (1969). Attempt to increase the effect of regional chemotherapy in experimental tumours by procaine.. PubMed. 16(4). 389–92. 1 indexed citations
20.
Godál, A, et al.. (1966). An attempt to potentiate the effect of chemotherapy by means of flow increasing in blood stream.. PubMed. 13(2). 149–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026